Author

Mahendra Chougule

Institution: Dr. Reddy's Laboratories (India)

Observed institutions: Dr. Reddy's Laboratories (India), National Institute of Pharmaceutical Education and Research

ORCID: 0009-0002-9861-1450

Observed ORCID: 0009-0002-9861-1450

OpenAlex ID: A5010987979

Enhanced biopharmaceutical performance of brick dust molecule nilotinib via stabilized amorphous nanosuspension using a facile acid–base neutralization approach

2023 · Mahendra Chougule, Arvind Sirvi, et al. · Drug Delivery and Translational Research · 19

Biopredictive Dissolutions for Conventional Oral IR, MR and Non-Oral Formulations – Current Status and Future Opportunities

2024 · Smritilekha Mondal, Sivacharan Kollipara, et al. · Journal of Drug Delivery Science and Technology · 13

A critical review on approaches to generate and validate virtual population for physiologically based pharmacokinetic models: Methodologies, case studies and way forward

2024 · Mahendra Chougule, Sivacharan Kollipara, et al. · European Journal of Clinical Pharmacology · 11

Conventional vs Mechanistic IVIVC: A Comparative Study in Establishing Dissolution Safe Space for Extended Release Formulations

2024 · Sivacharan Kollipara, Tausif Ahmed, et al. · AAPS PharmSciTech · 8

Playing Hide-and-Seek with Tyrosine Kinase Inhibitors: Can We Overcome Administration Challenges?

2024 · Sivacharan Kollipara, Mahendra Chougule, et al. · The AAPS Journal · 3

Nitrosamines Risk Assessment for Biopharmaceutics Classification System Class IV Molecule Containing Immediate Release Products: Use of In-Silico Prediction Tools and Physiologically Based Pharmacokinetic Modeling

2025 · Sivacharan Kollipara, Mahendra Chougule, et al. · The AAPS Journal · 2

Demonstrating Discriminatory Power of a Dissolution Method Using DDDPlus: Case Study of an Extended-Release Formulation and Use in Regulatory Justifications

2024 · Sivacharan Kollipara, Adithya Karthik Bhattiprolu, et al. · Dissolution Technologies · 2

Correction: Nitrosamines Risk Assessment for Biopharmaceutics Classifcation System Class IV Molecule Containing Immediate Release Products: Use of In-Silico Prediction Tools and Physiologically Based Pharmacokinetic Modeling

2025 · Sivacharan Kollipara, Mahendra Chougule, et al. · The AAPS Journal

Works count: 8

Citation count: 58

H-index: 4

I10-index: 3